In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist

被引：0
|
作者：
Kehne, John H. [1 ]
Bartoszyk, Gerd D. [2 ]
Greiner, Hartmut E. [2 ]
Pierz, Kerri A. [3 ]
Renda, Matthew J. [3 ]
van Amsterdam, Christoph [2 ]
Reed, Carol R. [3 ]
Athanasiou, Maria C. [3 ]
机构：
[1] Translat Neuropharmacol Consulting LLC, Execut, Rockville, MD USA
[2] Merck KGaA, Preclin Pharmaceut Res, Darmstadt, Germany
[3] PGxHealth LLC, Div Clin Data, Med Affairs, New Haven, CT USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
821
引用
收藏
页码：237S / 237S
页数：1
相关论文
共 50 条
  • [1] In Vivo and Ex Vivo Characterization of Vilazodone as a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
    Kehne, John H.
    Bartoszyk, Gerd D.
    Greiner, Hartmut E.
    Pierz, Kerri A.
    Renda, Matthew J.
    Reed, Carol R.
    Athanasiou, Maria C.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 238S - 238S
  • [2] Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone
    Hughes, ZA
    Staff, KR
    Langmead, CJ
    Hill, M
    Bartoszyk, GD
    Hagan, JJ
    Middlemiss, DN
    Dawson, LA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 510 (1-2) : 49 - 57
  • [3] Vilazodone hydrochloride -: Antidepressant -: 5-HT1A partial agonist -: 5-HT reuptake inhibitor
    Sorbera, LA
    Rabasseda, X
    Silvestre, J
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (03) : 247 - 252
  • [4] Electrophysiological Assessment of Accelerated 5-HT1A Autoreceptor Desensitization in Rats Produced by Vilazodone, a Novel Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
    Ashby, Charles R.
    Kehne, John H.
    Bartoszyk, Gerd D.
    Pierz, Kerri A.
    Renda, Matthew J.
    Athanasiou, Maria A.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 237S - 238S
  • [5] Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor
    Ashby, Charles R., Jr.
    Kehne, John H.
    Bartoszyk, Gerd D.
    Renda, Matthew J.
    Athanasiou, Maria
    Pierz, Kerri A.
    Seyfried, Christoph A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 714 (1-3) : 359 - 365
  • [6] Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
    Dawson, Lee A.
    Watson, Jeannette M.
    CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (02) : 107 - 117
  • [7] 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors
    Lovell, Peter J.
    Blaney, Frank E.
    Goodacre, Caroline J.
    Scott, Claire M.
    Smith, Paul W.
    Starr, Kathryn R.
    Thewlis, Kevin M.
    Vong, Antonio K. K.
    Ward, Simon E.
    Watson, Jeannette M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 1033 - 1036
  • [8] Trazodone Acts as a Serotonin (5-HT) Reuptake Inhibitor and 5-HT1A Receptor Agonist on the 5-HT System
    Ghanbari, Ramez
    El Mansari, Mostafa
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 242S - 242S
  • [9] Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor
    Stahl, Stephen M.
    CNS SPECTRUMS, 2014, 19 (02) : 105 - 109
  • [10] The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor
    Qin, Juan-Juan
    Chen, Hong-Xia
    Zhao, Nan
    Yuan, Li
    Zhang, You-Zhi
    Yang, Ri-Fang
    Zhang, Li-Ming
    Li, Yun-Feng
    NEUROSCIENCE LETTERS, 2014, 582 : 104 - 108
12345